Status:
UNKNOWN
Vaginal CO2 Laser and the Genitourinary Syndrome of Menopause
Lead Sponsor:
National and Kapodistrian University of Athens
Collaborating Sponsors:
IRCCS San Raffaele
Conditions:
Vaginal Atrophy
Eligibility:
FEMALE
Phase:
NA
Brief Summary
This study evaluates the clinical, histopathological, cytological and microbiological efficacy of Microablative Fractional CO2 laser intravaginally administered in postmenopausal women with Genitourin...
Eligibility Criteria
Inclusion
- Symptoms of vaginal atrophy (dyspareunia and/or vaginal dryness)
- Menopause
Exclusion
- Systemic or local hormonal therapy the last 6 months
- Use of moisturizers or lubricants the last month
- Active genital infection (i.e herpes, vaginitis)
- Prolapse stage \>=2
- Underlying pathologies that could interfere with the protocol compliance
Key Trial Info
Start Date :
January 18 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 15 2021
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT03754205
Start Date
January 18 2018
End Date
January 15 2021
Last Update
January 14 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Urogynecological Unit of Alexandra Hospital
Athens, Greece, 11528